Comment
doi: 10.1093/cid/ciz1193.
Cotrimoxazole Prophylaxis Selects for Antimicrobial Resistance in Human Immunodeficiency Virus-Exposed, Uninfected Infants
Affiliations
- PMID: 31832637
- PMCID: PMC7778347
- DOI: 10.1093/cid/ciz1193
Item in Clipboard
Comment
Cotrimoxazole Prophylaxis Selects for Antimicrobial Resistance in Human Immunodeficiency Virus-Exposed, Uninfected Infants
Clin Infect Dis.
.
No abstract available
Keywords: HIV-exposed uninfected; antibiotics; antimicrobial resistance; cotrimoxazole; infants; microbiome.
Comment on
-
Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus-Exposed, Uninfected Infants.Clin Infect Dis. 2020 Dec 31;71(11):2858-2868. doi: 10.1093/cid/ciz1186. Clin Infect Dis. 2020. PMID: 31832638 Free PMC article.
Similar articles
-
Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus-Exposed, Uninfected Infants.Clin Infect Dis. 2020 Dec 31;71(11):2858-2868. doi: 10.1093/cid/ciz1186. Clin Infect Dis. 2020. PMID: 31832638 Free PMC article.
-
Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV-exposed infants in a randomized controlled trial, Botswana.J Int AIDS Soc. 2017 Nov;20(3):e25021. doi: 10.1002/jia2.25021. J Int AIDS Soc. 2017. PMID: 29119726 Free PMC article. Clinical Trial.
-
Randomised controlled trial testing the effect of cotrimoxazole prophylaxis on morbidity and mortality outcomes in breastfed HIV-exposed uninfected infants: study protocol.BMJ Open. 2016 Jul 12;6(7):e010656. doi: 10.1136/bmjopen-2015-010656. BMJ Open. 2016. PMID: 27406638 Free PMC article. Clinical Trial.
-
Cotrimoxazole guidelines for infants who are HIV-exposed but uninfected: a call for a public health and ethics approach to the evidence.Lancet Glob Health. 2022 Aug;10(8):e1198-e1203. doi: 10.1016/S2214-109X(22)00120-6. Lancet Glob Health. 2022. PMID: 35839818 Review.
-
Cotrimoxazole prophylaxis in adults infected with HIV in low-income countries.Curr Opin Infect Dis. 2001 Oct;14(5):507-12. doi: 10.1097/00001432-200110000-00002. Curr Opin Infect Dis. 2001. PMID: 11964869 Review.
Cited by
-
Brief Report: Cessation of Long-Term Cotrimoxazole Prophylaxis in HIV-Infected Children Does Not Alter the Carriage of Antimicrobial Resistance Genes.J Acquir Immune Defic Syndr. 2020 Dec 15;85(5):601-605. doi: 10.1097/QAI.0000000000002489. J Acquir Immune Defic Syndr. 2020. PMID: 32852361 Free PMC article. Clinical Trial.
-
The association between early life antibiotic exposure and the gut resistome of young children: a systematic review.Gut Microbes. 2022 Jan-Dec;14(1):2120743. doi: 10.1080/19490976.2022.2120743. Gut Microbes. 2022. PMID: 36289062 Free PMC article.
References
-
- Joint United Nations Programme on HIV/AIDS. AIDSInfo: elimination of mother-to-child transmission Available at: http://aidsinfo.unaids.org/. Accessed 20 November 2019.
-
- Brennan AT, Bonawitz R, Gill CJ, et al. . A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared with HIV-unexposed uninfected infants and children. AIDS 2016; 30:2351–60. - PubMed
-
- Evans C, Jones CE, Prendergast AJ. HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. Lancet Infect Dis 2016; 16:e92–107. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
